Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety - Top-Institutions - MDSpire

Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety

By
Federica Vinciguerra
Carla Di Stefano
Fabio Guccione
Claudia Degano
Stefania Nigro
Roberto Baratta
Luigi Piazza
Giuseppe Navarra
Lucia Frittitta
June 5, 2026
0 min

Obesity Surgery

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, Minnesota
Key Differentiators
- Obesity Medicine
- Endocrinology
- Bariatric Surgery
#2

Mass General Brigham

Boston, Massachusetts
Key Differentiators
- Obesity Medicine
- Bariatric Surgery
#3

Cleveland Clinic

Cleveland, Ohio
Key Differentiators
- Obesity Medicine
- Bariatric Surgery
#4

Allegheny General Hospital

Pittsburgh, Pennsylvania
Key Differentiators
- Obesity Medicine
#5

Ramsay Health Care NSW

New South Wales, Australia
Key Differentiators
- Obesity Medicine

Original Source(s)

Obesity Surgery

Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety

by Federica Vinciguerra, Carla Di Stefano, Fabio Guccione, Claudia Degano, Stefania Nigro, Roberto Baratta, Luigi Piazza, Giuseppe Navarra, Lucia Frittitta
June 5, 2026

Related Content

Nature Medicine

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial

Frontiers In Endocrinology

Reorienting catch-up growth research toward early-life prevention of metabolic disorders using natural products

by Hendra Stevani, Habibie Habibie, Asbah Asbah, Firzan Nainu
May 28, 2026

Conexiant

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

by Kathryn Wighton
May 27, 2026
6 min